Risk factors of thyroid carcinoma

Česká verzia

Authors: Dana Nováková; Martin Křenek; Květuše Vošmiková; Petr Vlček
Authors place of work: Klinika nukleární medicíny a endokrinologie 2. LF UK a FN Motol Praha, přednosta prof. MUDr. Petr Vlček, CSc.
Published in the journal: Vnitř Lék 2015; 61(7-8): 655-659
Category: Reviews

Summary

Thyroid cancer is one of the world’s fastest growing tumor incidences. The number of new cases has particularly increased in differentiated papillary thyroid carcinoma. In the Czech Republic it is documented that the incidence of thyroid cancer continues to grow, since 1980 has increased four times. The Czech Republic has a higher incidence than most other European countries and at the same time is a country with average and declining mortality from this disease. This review summarizes the known risk factors that may contribute to the formation and rise of thyroid carcinomas.

Key words:
differentiated thyroid carcinoma – incidence – low risk carcinoma – microcarcinoma – risk factors

Zdroje

1. Aschebrook-Kilfoy B, Grogan RH, Ward MH et al. Follicular thyroid cancer incidence patterns in the United States, 1980–2009. Thyroid 2013; 23(8): 1015–1021.

2. Avanzi S, Alvisi G, Ripalti A. How virus persistence can initiate the tumorigenesis process. World J Virol 2013; 2(2): 102–109.

3. Balkan F, Onal ED, Usluogullari A et al. Is there any association between insulin resistance and thyroid cancer? A case control study. Endocrine 2014; 45(1): 55–60.

4. Brito JP, Yarur AJ, Prokop LJ et al. Prevalence of thyroid cancer in multinodular goiter versus single nodule: a systematic review and meta-analysis. Thyroid 2013; 23(4): 449–455.

5. CDC 2010 Smoking and tobacco use. Chemical in Tobacco Smoke. Atlanta: CDC. Dostupné z WWW: <http://www.cdc.gov/tobacco/data_statistics/sgr/2010/consumer_booklet/chemicals_smoke/>.

6. Choi WJ, Kim J. Dietary factors and the risk of thyroid cancer: a review. Clin Nutr Res 2014; 3(2): 75–88.

7. Dijkstra B, Prichard RS, Lee A et al. Changing patterns of thyroid carcinoma. Ir J Med Sci 2007; 176(2): 87–90.

8. Dvorkin S, Robenshtok E, Hirsch D et al. Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. J Clin Endocrinol Metab 2013; 98(6): 2409–2414.

9. Fallah M, Pukkala E, Tryggvadottir L et al. Risk of thyroid cancer in first-degree relatives of patients with non-medullarythyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J Med Genet 2013; 50(6): 373–382.

10. Feldt-Rasmussen U. Iodine and cancer. Thyroid 2001; 11(5): 483–486.

11. Fiore E, Rago T, Provenzale MA et al. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients. Endocr Relat Cancer 2010; 17(1): 231–239.

12. Grodski S, Brown T, Sidhu S et al. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 2008; 144(6): 1038–1043.

13. Haber MH, Lipkovic P. Thyroid cancer in Hawaii. Cancer 1970; 25(5): 1224–1227.

14. Handkiewcz-Junak D, Banasik T, Kolosza Z et al. Risk of malignant tumors in first-degree relatives of patients withdifferentiated thyroid cancer – a hospital based study. Neoplasma 2006; 53(1): 67–72.

15. Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med 2004; 351(17): 1764–1771.

16. Howlader N, Noone A, Krapcho M et al. 2013 SEER Cancer Statistics Review, 1975–2010. Bethesda (MD): National Cancer Institute. Dostupné z WWW: http://seer.cancer.gov/csr/1975_2010. Based on November 2012 SEER data submission, posted to the SEER web site, April 2013.

17. Kabat GC, Kim MY, Wactawski-Wende J et al. Menstrual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women. Cancer Causes Control 2012; 23(12): 2031–2040.

18. Konturek A, Barczyński M, Wierzchowski W et al. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch Surg 2013; 398(3): 389–394.

19. Krátký J, Vítková H, Bartáková J et al. Thyroid nodules: pathophysiological insight on oncogenesis and novel diagnostic techniques. Physiol Res 2014; 63(Suppl 2): S263-S275.

20. Lehrer S, Rosenzweig KE. Cold Climate Is a Risk Factor for Thyroid Cancer. Clin Thyroidol 2014; 26(10): 273–276.

21. Liu X, Zhu L, Cui D et al. Coexistence of Histologically Confirmed Hashimoto‘s Thyroiditis with Different Stages of Papillary Thyroid Carcinoma in a Consecutive Chinese Cohort. Int J Endocrinol 2014; 2014: 769294. Dostupné z DOI: <http://dx.doi.org/10.1155/2014/769294>.

22. Lukas J, Drabek J, Lukas D et al. The epidemiology of thyroid cancer in the Czech Republic in comparison with other countries. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013; 157(3): 266–275.

23. Marcello MA, Malandrino P, Almeida JF et al. The influence of the environment on the development of thyroid tumors: a new appraisal. Endocr Relat Cancer 2014; 21(5): T235-T235.

24. Mettler jr. FA, Bhargavan M, Thomadsen BR et al. Nuclear medicine exposure in the United States, 2005–2007: preliminary results. Semin Nucl Med 2008; 38(5): 384–391.

25. Ondrusova M, Kajo K, Ondrus D. Changing patterns in thyroid cancer incidence and mortality in the Slovak Republic by histological type and age. Int J Clin Oncol 2014; 19(5): 805–813.

26. Pellegriti G, Frasca F, Regalbuto C et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013; 2013: 965212. Dostupné z DOI: <http://dx.doi.org/10.1155/2013/965212>.

27. Pellegriti G, De Vathaire F, Scollo C et al. Papillary thyroid cancer incidence in the volcanic area of Sicily. J Natl Cancer Inst 2009; 101(22): 1575–1583.

28. Peterson E, De P, Nuttall R. BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS One 2012; 7: e29177. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0029177>.

29. Robbins J, Merino MJ, Boice jr. JD et al. Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med 1991; 115(2): 133–147.

30. Ron E, Lubin JH, Shore RE et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141(3): 259–277.

31. Tsai JH, Tsai CH, Cheng MH et al. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol 2005; 75(2): 276–281.

32. Tung-Sun Huang, Jie-Jen Lee, Shih-Ping Cheng. No evidence of association between human cytomegalovirus infection and papillary thyroid cancer. World J Surg Oncol 2014; 12: 41. Dostupné z DOI: <http://dx.doi.org/10.1186/1477–7819–12–41>.

33. Wang F, Wang Y, Wang L et al. Strong association of high urinary iodine with thyroid nodule and papillary thyroid cancer. Tumour Biol 2014; 35(11): 11375–11379.

34. Williams D. Cancer after nuclear fallout: lessons from the Chernobyl accident. Nat Rev Cancer 2002; 2(7): 543–549.

35. Zafon C, Obiols G. The mitogen-activated protein kinase (MAPK) signaling pathway in papillary thyroid cancer. From the molecular bases to clinical practice. Endocrinol Nutr 2009; 56(4): 176–186.

36. Zamora-Ros R, Rinaldi S, Biessy C et al. Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study. Int J Cancer 2015; 136(5): 1218–1227.